Lotus Pharmaceutical Co., Ltd.

TWSE:1795 주식 보고서

시가총액: NT$74.7b

Lotus Pharmaceutical 대차 대조표 상태

재무 상태 기준 확인 5/6

Lotus Pharmaceutical 의 총 주주 지분은 NT$20.2B 이고 총 부채는 NT$12.1B, 이는 부채 대 자기자본 비율을 60% 로 가져옵니다. 총자산과 총부채는 각각 NT$37.2B 및 NT$17.0B 입니다. Lotus Pharmaceutical 의 EBIT는 NT$5.3B 이며 이자보상배율은 10.9 입니다. NT$3.7B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

60.0%

부채 비율

NT$12.13b

부채

이자 보상 비율10.9x
현금NT$3.69b
주식NT$20.22b
총 부채NT$17.02b
총 자산NT$37.23b

최근 재무 상태 업데이트

Recent updates

Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 16
Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Lotus Pharmaceutical's (TWSE:1795) Earnings Are Weaker Than They Seem

Nov 14
Lotus Pharmaceutical's (TWSE:1795) Earnings Are Weaker Than They Seem

Here's Why Lotus Pharmaceutical (TWSE:1795) Has A Meaningful Debt Burden

Oct 23
Here's Why Lotus Pharmaceutical (TWSE:1795) Has A Meaningful Debt Burden

Lotus Pharmaceutical Co., Ltd. Just Missed Revenue By 5.2%: Here's What Analysts Think Will Happen Next

Aug 14
Lotus Pharmaceutical Co., Ltd. Just Missed Revenue By 5.2%: Here's What Analysts Think Will Happen Next

Investors Continue Waiting On Sidelines For Lotus Pharmaceutical Co., Ltd. (TWSE:1795)

Jul 18
Investors Continue Waiting On Sidelines For Lotus Pharmaceutical Co., Ltd. (TWSE:1795)

Is Lotus Pharmaceutical (TWSE:1795) Using Too Much Debt?

Apr 24
Is Lotus Pharmaceutical (TWSE:1795) Using Too Much Debt?

Benign Growth For Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Underpins Its Share Price

Apr 09
Benign Growth For Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Underpins Its Share Price

Lotus Pharmaceutical's (TWSE:1795) Solid Profits Have Weak Fundamentals

Mar 22
Lotus Pharmaceutical's (TWSE:1795) Solid Profits Have Weak Fundamentals

These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively

Apr 04
These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively

Lotus Pharmaceutical Co., Ltd.'s (TPE:1795) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 09
Lotus Pharmaceutical Co., Ltd.'s (TPE:1795) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Did You Miss Lotus Pharmaceutical's (TPE:1795) 64% Share Price Gain?

Feb 11
Did You Miss Lotus Pharmaceutical's (TPE:1795) 64% Share Price Gain?

Should You Use Lotus Pharmaceutical's (TPE:1795) Statutory Earnings To Analyse It?

Jan 21
Should You Use Lotus Pharmaceutical's (TPE:1795) Statutory Earnings To Analyse It?

Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?

Dec 31
Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?

I Ran A Stock Scan For Earnings Growth And Lotus Pharmaceutical (TPE:1795) Passed With Ease

Dec 10
I Ran A Stock Scan For Earnings Growth And Lotus Pharmaceutical (TPE:1795) Passed With Ease

Lotus Pharmaceutical Co., Ltd. Just Missed EPS By 6.5%: Here's What Analysts Think Will Happen Next

Nov 19
Lotus Pharmaceutical Co., Ltd. Just Missed EPS By 6.5%: Here's What Analysts Think Will Happen Next

재무 상태 분석

단기부채: 1795 의 단기 자산 ( NT$15.6B )이 단기 부채( NT$6.1B ).

장기 부채: 1795 의 단기 자산( NT$15.6B )이 장기 부채( NT$10.9B ).


부채 대 자본 내역 및 분석

부채 수준: 1795 의 순부채 대 자기자본 비율( 41.8% )은 높음으로 간주됩니다.

부채 감소: 1795 의 부채 대 자기자본 비율은 지난 5년간 91.5% 에서 60% 로 감소했습니다.

부채 범위: 1795 의 부채는 영업 현금 흐름 ( 38.1% )에 의해 잘 충당되었습니다.

이자 보장: 1795 의 부채에 대한 이자 지급EBIT( 10.9 x 적용 범위)로 잘 충당됩니다.


대차 대조표


건강한 기업 발견하기